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studyquestion:Which essential items should be recorded before, during and after endometriosis surgery and in clinical outcome based
surgical trials in patients with deep endometriosis (DE)?
summaryanswer: A DE surgical sheet (DESS) was developed for standardized reporting of the surgical treatment of DE and an inter-
national expert consensus proposal on relevant items that should be recorded in surgical outcome trials in women with DE.
what is known already: Surgery is an important treatment for symptomatic DE. So far, data have been reported in such a way that
comparison of different surgical techniques is impossible. Therefore, we present an international expert proposal for standardized reporting of
surgical treatment and surgical outcome trials in women with DE.
study design, size, duration: International expert consensus based on a systematic review of literature.
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participants/materials, setting, methods: Taking into account recommendations from Consolidated Standards of
Reporting Trials (CONSORT), the Innovation Development Exploration Assessment and Long-term Study (IDEAL), the Initiative on
Methods, Measurement and Pain Assessment in Clinical trials (IMMPACT) and the World Endometriosis Research Foundation
Phenome and Biobanking Harmonisation Project (WERF EPHect), a systematic literature review on surgical treatment of DE was per-
formed and resulted in a proposal for standardized reporting, adapted by contributions from eight members of the multidisciplinary
Leuven University Hospitals Endometriosis Care Program, from 18 international experts and from audience feedback during three inter-
national meetings.
main results and the role of chance: We have developed the DESS to record in detail the surgical procedures for DE,
and an international consensus on pre-, intra- and post-operative data that should be recorded in surgical outcome trials on DE.
limitations, reasons for caution: The recommendations in this paper represent a consensus among international experts
based on a systematic review of the literature. For several items and recommendations, high-quality RCTs were not available. Further
research is needed to validate and evaluate the recommendations presented here.
wider implications of the findings: This international expert consensus for standardized reporting of surgical treatment
in women with DE, based on a systematic literature review and international consensus, can be used as a guideline to record and
report surgical management of patients with DE and as a guideline to design, execute, interpret and compare clinical trials in this
patient population.
study funding/competing interest(s): None of the authors received funding for the development of this paper. M.A.
reports personal fees and non-ﬁnancial support from Bayer Pharma outside the submitted work; H.T. reports a grant from Pﬁzer and
personal fees for being on the advisory board of Perrigo, Abbvie, Allergan and SPD.
trial registration number: N/A.
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Introduction
Deep endometriosis (DE) is amultifocal pathologywhichmay inﬁltrate
different pelvic locations andorgans (Chapron et al., 2010). Surgery for
DE appears effective, but is associated with signiﬁcant complication
rates (Dunselman et al., 2014). Several techniques for the excision
of DE have been described, but large, prospective RCTs are lacking.
Systematic reviews on the surgical treatment of DE demonstrated
that it is impossible to compare the literature owing to unclear
deﬁnitions, lack of standardization and incompleteness in report-
ing (De Cicco et al., 2011; Meuleman et al., 2011). Therefore, we
believe that an initiative is needed for the standardization of data
collection in surgical trials on DE.
Inspired by theWorld Endometriosis Research Foundation Phenome
and Biobanking Harmonisation Project (WERF-EPHect) and the IDEAL-
recommendations (Innovation Development Exploration Assessment
and Long-term study) for improving surgical innovation and evaluation,
wepresent in this paperaConsensusOnRecordingDeepEndometriosis
Surgery (CORDES) (McCulloch et al., 2009; Casper, 2014). This Execu-
tiveSummaryof theCORDES statement summarizes two full-length arti-
cles that are available online in Human Reproduction: in the ﬁrst article
(Vanhie et al., 2016 Part I, Supplementary Data) we propose a deep
endometriosis surgical sheet (DESS) for the standardized reporting of
surgery for DE; in the second article (Vanhie et al., 2016 Part II, Supple-
mentaryData)wepresent a consensus for the standardization of report-
ing surgical trials in patients with DE.
Methods
A systematic literature searchwas performed using the search terms ‘deeply
inﬁltrating endometriosis’ and ‘deep endometriosis’ in combination with
‘treatment’. A total of 26 reviews, systematic reviews and meta-analyses
were identiﬁed and analyzed in detail for data about reporting of endometri-
osis surgery. Through cross-referencing 25 additional relevant publications
were identiﬁed and included (Vanhie et al., Part 1, Supplementary Table SI).
CORDES Part I: standardized reporting of
surgical procedures (Vanhie et al., 2016
Part I)
Basedon the results of this literature search, theWERF-EPHect surgical form
(Becker et al., 2014) and an existing checklist (Meuleman et al., 2011, 2012),
we developed a ﬁrst draft version of the ‘deep endometriosis surgical sheet’
(DESS), where all items were precisely deﬁned.
This draft was then reviewed and adapted by senior staff members of the
multidisciplinary Leuven Endometriosis Surgical Team until a consensus was
reached. During the next stage, international experts were contacted and
were asked to offer feedback. All authors reviewed the manuscript and pro-
vided feedback, gave comments and/oradded items.This resulted in the ﬁnal
version of the DESS, which was then presented for approval to all coauthors
(Vanhie et al., 2016 Part I).
CORDES Part II: standardized reporting
of surgical trials (Vanhie et al., 2016 Part II)
Based on the results of the literature search, we extended an existing
CONSORT-based checklist (Meuleman et al., 2011, 2012) to delineate
the essential items in reporting of baseline data, interventions and
outcome assessment. Subsequently, all items from the extended checklist
were precisely deﬁned and the checklist was adapted until consensus was
reached among the members of the multidisciplinary Leuven Endometriosis
Surgical Team.
During the second stage, international experts were contacted and asked
to offer feedback. All authors reviewed the manuscript, provided feedback,
gave comments and/or added items. This resulted in the ﬁnal version of the
international expert consensus, which was approved by all coauthors.
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In Part I we have developed theDESS,which is available as an online pub-
lication in Human Reproduction (Vanhie et al., 2016 Part I). In Table I an
overview of the recommendations in the DESS is presented. In the
online paper we also propose detailed deﬁnitions for all surgical proce-
dures used in the treatment of DE (Vanhie et al., 2016 Part I).
In Part II we have developed an international expert consensus on the
reporting of surgical trials in women with DE, which is available as a
second online publication in Human Reproduction (Vanhie et al., 2016
Part II). In Table II a general overview is presented of these recommen-
dations for standardized reporting of surgical trials in womenwith DE. In
the online paper,we also propose deﬁnitions for different types of recur-
rence of endometriosis and all other items used in the CORDES state-
ment (Vanhie et al., 2016 Part II).
Conclusion
TheDESS (Vanhie et al., 2016Part I) is anexhaustive surgical sheet includ-
ing more items than routinely recorded in current research databases,
and including all items of the WERF EPHect surgical form, which is a
ﬁrst major strength (Becker et al., 2014). This ensures that the recorded
information cannotonly beused for surgical researchpurposes but is also
alignedwith theEPHect standard forbiobank samples andendometriosis
research in general, which compensates for the extra time invested in the
recording of the DESS. A second very important strength of the DESS is
its ‘ready to use’ format which allows easy implementation, also for
centers that do not routinely record and report their surgical data. A
third strength is that the DESS can be used as a basis for national/inter-
national registries, allowing each registration authority ﬂexibility in quality
control by deﬁning essential and non-essential ﬁelds within the DESS.
In Part II of the CORDES statements (Vanhie et al., 2016 Part II) we
included, where possible, patient reported outcomes for the assessment
of different aspects relevant in trials on surgical management of endometri-
osis. Recently, patient reportedoutcomes related toqualityof life havebeen
used increasingly andhavebeenwidely acceptedas a solidprimaryoutcome
measure in scientiﬁc trials (Kluivers et al., 2008; Vincent et al., 2010). The
majority of other outcome variables recommended in Part II (Vanhie
et al., 2016 Part II) have been selected because they are well known,
widely used and recommended by different authors and institutions.
In Part II (Vanhie et al., 2016Part II),wehavedevelopeddeliberately an
exhaustive list of recommendations to avoid bias asmuch as possible. It is
obvious that it is practically impossible to use all variables together in one
study/register/database, and that investigators may be selective de-
pending on their hypothesis and objectives. Nevertheless, in view of
the recommendations listed in Part II (Vanhie et al., 2016 Part II), each
investigator will be challenged to clearly document why certain
CORDES outcome variables were included or omitted in their study.
As such, the recommendations from Part II (Vanhie et al., 2016 Part II)
will stimulate a more rigorous development of study protocols and
better reporting of the results. To this end, our proposal will support
the planning, execution and interpretation of high quality surgical trials
that are urgently needed to better understand what constitutes
optimal surgical treatment for women with DE, and that represent the




Thepaperwasprimarily designed andwrittenby the ﬁrst authorA.V. and
by last author T.D. All other coauthors contributed signiﬁcantly to the
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papers, critically reviewed and improved draft versions of this paper.
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Table I Standardized reporting of surgical treatment
for deep endometriosis: summary of the deep
endometriosis surgical sheet (DESS).
Record essential pre-operative information
† Essential clinical covariates
† Menstrual history and current hormonal treatment
† Previous endometriosis surgery
† Pre-operative imaging results
† Use of prophylactic drugs
† Indications and decision on type of surgery
Record detailed description and staging of endometriosis
† Staging: ASRM and EFI (optional: ENZIAN)
† Extent of peritoneal/superﬁcial endometriosis
† Number, size and exact localization of each lesion
† Extent of ovarian endometriosis
† Number, size and localization of endometrioma(s)
† Extent of deep endometriosis
† Number, size and exact localization of each lesion
† Bowel DE:
B Depth of inﬁltration in intestinal wall
B Circumferential involvement
B Distance to anal verge
† Urological DE:
B Depth of inﬁltration in bladder and ureter
B Presence of hydro-ureteronephrosis
† Extent of adhesions
Record detailed description of surgical procedures performed
† Clear description of surgical procedures performed (standardized
terminology)
† Record surgical risk factors for negative outcomes
Record essential post-operative information
† Operation times, length of hospital stay and post-operativemanagement
† Detailed description of the abdomen after surgery
† Detailed histological report
† Intra and post-operative complications
ASRM, American Society for Reproductive Medicine; EFI, endometriosis fertility
index; DE, deep endometriosis.
Consensus on Reporting Deep Endometriosis Surgery CORDES 1221








Table II Standardized reportingof surgical trials forDE.




Participants Record WERF-EPHect EPQ for all patients
Report detailed description of the population studied
† Age, BMI and ethnicity
† Medication and substance use
† Medical history and treatment
† Menstrual history
† Previous use of hormonal treatment
† Previous diagnosis of endometriosis
† Previous therapeutic surgery
† Obstetrical history
† Family history of endometriosis
Report detailed description of pre-operative work-up
† Details on imaging techniques used
† Detailed description of results: pre-operative
endometriosis mapping
Interventions Report details on indications for surgery
† Pain symptoms without infertility
† Pain symptoms with infertility
† Infertility without pain symptoms
† No infertility or pain symptoms
† Asymptomatic hydro-ureteronephrosis
Report details on decisions on type/technique of
surgery
† Pre or intra-operative decision
† Decision criteria/treatment algorithm
Report interventions using the DESS:
† Description endometriosis at start of surgery
† Staging of endometriosis: ASRM + EFI (+ENZIAN)
† Standardized description of all surgical procedures
† Description of abdomen at end of surgery
Report detailed histological results
† Histologic conﬁrmation of endometriosis + histologic
type/pattern
† Largest diameter of each lesion
† Depth of invasion (in bowel, bladder, ureter, . . . ) for
each lesion
† Bowel specimens:
† Presence of lymphatic dissemination
† Median length of the resected bowel segments
(in cm)
† Number + location of positive section margins
Results Report details on all primary outcomes
Pain
† Daily ratings with 11-point NRS
† Separate ratings for: dyspareunia, dysmenorrhea,
chronic pelvic pain, dyschezia and mictalgia
† Record and report concomitant use of other drugs/
analgesics/therapies






† Assessment at baseline (minimum 1) + follow up
(minimum 1)
Fertility
† Report cumulative pregnancy rate
† Report details on mode of conception





† Report all complications + management + outcome
in absolute numbers
† Classify complications according to Clavien-Dindo
† Report comprehensive complication index (CCI)
Report details on secondary outcomes
Sexual function
† Deﬁne method use for assessment of sexual
(dys)function
† Assessment at baseline (minimum 1) + follow up
(minimum 1)
† Suggested PRO’s:
† FSFI ¼ Female sexual function index
† MFSQ ¼ McCoy Female Sexuality
Questionnaire
† GSSI ¼ Global Sexual Satisfaction Index
Urinary function
† Deﬁne the method used for assessment of urinary
(dys)function
† Recommended use of PROcombinedwith urodynamics
† Assessment at baseline (minimum 1) + follow up
(minimum 1)
† Suggested PRO: BFLUTS (¼ICIQ-FLUTS)
Bowel function
† Deﬁne the method used for assessment of bowel
(dys)function
† Assessment at baseline (minimum 1) + follow up
(minimum 1)
† Suggested PRO’s:
† General GI-symptoms: GIQLI
† Constipation: KESS
† Incontinence: FIQLI
† Classiﬁcation of feces: Bristol Stool Chart
Optional: report details on tertiary outcomes
Cost-effectiveness
Recovery: QoR-40 or CARE
Patient centeredness: ENDOCARE-questionnaire
WERF-EPHect EPQ, World Endometriosis Research Foundation Phenome and
Biobanking Harmonisation Project; EPQ, Endometriosis Patient Questionnaire; NRS,
numerical rating scale; QoL, quality of life; PRO, patient reported outcome; BFLUTS,
Bristol Female Lower Urinary Tract Scale; ICIQ, International Consultation on
Incontinence Modular Questionnaire; FLUTS, Female Lower Urinary Tract
Symptoms; GIQLI, Gastrointestinal Quality of life Index; KESS,
Knowles-Eccersley-Scott Symptom questionnaire; FIQLI, Fecal Incontinence Quality
of Life scale.
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